Published in Reprod Health Matters on November 01, 2010
Change in abortion services after implementation of a restrictive law in Texas. Contraception (2014) 2.79
Impact of Clinic Closures on Women Obtaining Abortion Services After Implementation of a Restrictive Law in Texas. Am J Public Health (2016) 1.23
The public health threat of anti-abortion legislation. Contraception (2013) 1.01
Women's experiences seeking abortion care shortly after the closure of clinics due to a restrictive law in Texas. Contraception (2016) 0.91
Exploring pregnancy termination experiences and needs among Malaysian women: a qualitative study. BMC Public Health (2012) 0.77
TRAP laws and the invisible labor of US abortion providers. Crit Public Health (2015) 0.75
Women's experiences seeking informal sector abortion services in Cape Town, South Africa: a descriptive study. BMC Womens Health (2017) 0.75
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet (2010) 3.59
The supreme court and the Partial-Birth Abortion Ban Act of 2003: a political procedure replaces woman-centered care. MedGenMed (2007) 3.28
Integrating abortion training into family medicine residency programs. Fam Med (2007) 2.39
Where is the "E" in MCH? The need for an evidence-based approach in safe motherhood. J Midwifery Womens Health (2003) 2.36
A descriptive analysis of abortion training in family medicine residency programs. Fam Med (2007) 2.23
Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period. Contraception (2005) 2.17
Embracing post-fertilisation methods of family planning: a call to action. J Fam Plann Reprod Health Care (2013) 2.04
A Review of Contraception and Abortion Content in Family Medicine Textbooks. Fam Med (2015) 1.97
Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG (2005) 1.94
Re: Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy. Contraception (2009) 1.92
The impact of the work environment on condom use among female bar workers in the Philippines. Health Educ Behav (2002) 1.92
Acceptability of Carraguard vaginal gel use among Thai couples. AIDS (2006) 1.65
Better than nothing or savvy risk-reduction practice? The importance of withdrawal. Contraception (2009) 1.62
Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews. J Clin Epidemiol (2008) 1.60
Infection after medical abortion: a review of the literature. Contraception (2004) 1.51
Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone. Contraception (2010) 1.46
First trimester procedural abortion in family medicine. J Am Board Fam Med (2009) 1.43
Misoprostol alone for early abortion: an evaluation of seven potential regimens. Contraception (2005) 1.43
Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception (2004) 1.39
Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice. J Gen Intern Med (2012) 1.39
Effectiveness and acceptability of medical abortion provided through telemedicine. Obstet Gynecol (2011) 1.39
Community-based kangaroo mother care to prevent neonatal and infant mortality: a randomized, controlled cluster trial. Pediatrics (2008) 1.39
Determinants of intrauterine contraception provision among US family physicians: a national survey of knowledge, attitudes and practice. Contraception (2010) 1.32
A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol (2005) 1.31
Knowledge and likelihood to recommend intrauterine devices for adolescents among school-based health center providers. J Adolesc Health (2012) 1.31
Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial. J Acquir Immune Defic Syndr (2006) 1.30
Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis (2010) 1.29
First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review. Contraception (2012) 1.27
A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand. Sex Transm Dis (2008) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Acceptability and feasibility of medical abortion in Nepal. Int J Gynaecol Obstet (2009) 1.16
Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol (2007) 1.13
Misoprostol for women's health: a review. Obstet Gynecol (2002) 1.11
Non-physician clinicians can safely provide first trimester medical abortion. Reprod Health Matters (2009) 1.10
Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception (2002) 1.10
Effects of iron supplementation on maternal hematologic status in pregnancy. Am J Public Health (2002) 1.09
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08
The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One (2008) 1.06
Health disparities training in residency programs in the United States. Fam Med (2015) 1.05
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana. Int J Gynaecol Obstet (2010) 1.04
Assessment of service availability and health care workers' opinions about young women's sexual and reproductive health in Soweto, South Africa. Afr J Reprod Health (2012) 1.04
Male circumcision for HIV prevention: clinical practices and attitudes among healthcare providers in South Africa and Zimbabwe. Sex Transm Dis (2012) 1.03
Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol (2011) 1.02
Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa. J Fam Plann Reprod Health Care (2008) 1.01
Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception (2007) 1.01
Underuse of the IUD in contraceptive care and training. Fam Med (2010) 1.01
The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav (2008) 1.00
Alternatives to a routine follow-up visit for early medical abortion. Obstet Gynecol (2010) 0.99
Adaptation of kangaroo mother care for community-based application. J Perinatol (2003) 0.98
Medicaid funding for abortion: providers' experiences with cases involving rape, incest and life endangerment. Perspect Sex Reprod Health (2010) 0.98
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial. Sex Transm Dis (2011) 0.97
Students as patients and teachers: evaluation of an experiential emergency contraception project. Fam Med (2011) 0.96
A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. Int J Gynaecol Obstet (2010) 0.96
Medical abortion: the possibilities for introduction in the public sector in South Africa. Reprod Health Matters (2005) 0.96
A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion. Contraception (2005) 0.96
Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception (2009) 0.96
Complications after second trimester surgical and medical abortion. Reprod Health Matters (2008) 0.96
Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana. Afr J Reprod Health (2010) 0.95
Acceptability of home-use of misoprostol in medical abortion. Contraception (2004) 0.95
How effective are the components of active management of the third stage of labor? BMC Pregnancy Childbirth (2013) 0.94
Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next? Int J Gynaecol Obstet (2012) 0.94
Urban female patients' perceptions of the family medicine clinic as a site for abortion care. Contraception (2009) 0.94
Misoprostol for postpartum hemorrhage: moving from evidence to practice. Int J Gynaecol Obstet (2011) 0.94
Medical education for social justice: Paulo Freire revisited. J Med Humanit (2006) 0.93
Barriers to contraceptive use in product labeling and practice guidelines. Am J Public Health (2006) 0.93
Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study. Contraception (2012) 0.93
Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG (2004) 0.92
Carraguard acceptability among men and women in a couples study in Thailand. J Womens Health (Larchmt) (2010) 0.92
Women's preference for receiving abortion in primary care settings. J Womens Health (Larchmt) (2010) 0.92
Willingness of clinicians to integrate microbicides into HIV prevention practices in southern Africa. AIDS Behav (2012) 0.92
Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC Pregnancy Childbirth (2012) 0.92
No increase in cervicovaginal proinflammatory cytokines after Carraguard use in a placebo-controlled randomized clinical trial. J Acquir Immune Defic Syndr (2008) 0.92
Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh. Int Perspect Sex Reprod Health (2013) 0.90
Interest in over-the-counter access to oral contraceptives among women in the United States. Contraception (2013) 0.90
DMPA and HIV: do we need a trial? Contraception (2014) 0.90
A mystery caller evaluation of Medicaid staff responses about state coverage of abortion care. Womens Health Issues (2011) 0.90
Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial. Obstet Gynecol (2014) 0.90
Multicenter trial of a simplified mifepristone medical abortion regimen. Obstet Gynecol (2005) 0.89
Misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria. Int J Gynaecol Obstet (2012) 0.89
A systematic review of the relationship between blood loss and clinical signs. PLoS One (2013) 0.89
The visit before the morning after: barriers to preprescribing emergency contraception. Ann Fam Med (2004) 0.89
Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone. Eur J Contracept Reprod Health Care (2009) 0.88
Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opin Investig Drugs (2012) 0.88
Developing built environment programs in local health departments: lessons learned from a nationwide mentoring program. Am J Public Health (2014) 0.88
Emergency contraception in Honduras: knowledge, attitudes, and practice among urban family planning clients. Stud Fam Plann (2006) 0.88
Determinants of differential HIV incidence among women in three southern African locations. J Acquir Immune Defic Syndr (2011) 0.87
Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception (2004) 0.87
Barriers to adolescents' getting emergency contraception through pharmacy access in California: differences by language and region. Perspect Sex Reprod Health (2009) 0.86
Intimate partner violence and condom and diaphragm nonadherence among women in an HIV prevention trial in southern Africa. J Acquir Immune Defic Syndr (2013) 0.86
Acceptability of home use of mifepristone for medical abortion. Contraception (2012) 0.86
Family planning training in US family medicine residencies. Fam Med (2011) 0.86
Bringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal. Contraception (2003) 0.85